Marché mondial du traitement de la maladie de Buerger – Tendances et prévisions du secteur jusqu'en 2030

Analyse et taille du marché du traitement de la maladie de Buerger

Les économies en développement sont des marchés majeurs pour le traitement de la maladie de Buerger en raison de l'expansion des infrastructures de soins de santé dans ces économies. Les principaux acteurs du marché opérant sur ce marché se concentrent sur l'expansion de leurs portefeuilles de produits en faisant émerger de nouveaux produits présentant des effets secondaires réduits et une efficacité accrue pour traiter la maladie de Buerger. Le développement économique, l'augmentation du revenu disponible des patients et la sensibilisation aux soins de santé en Asie et en Amérique latine incitent peu à peu les principaux acteurs à étendre leurs activités dans ces régions.

Data Bridge Market Research analyse le taux de croissance du marché du traitement de la maladie de Buerger au cours de la période de prévision 2023-2030. Le TCAC attendu du marché du traitement de la maladie de Buerger a tendance à être d'environ 5,50 % au cours de la période de prévision mentionnée. Le marché était évalué à 390,95 millions USD en 2022 et devrait atteindre 600 millions USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de recherche sur le marché de Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché du traitement de la maladie de Buerger

Market Definition

Buerger’s disease is a genetic condition which often affects young or middle-aged male smokers. This is typically characterized by narrowing or obstruction of the extremities' veins and arteries, that leads to a decreased blood supply to these areas as peripheral vascular disease. The exact causes of this disease are not really known but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud's phenomenon and such. There is no 100% cure for this disease.

Global Buerger’s Disease Treatment Market Dynamics

Drivers

• High Prevalence of Cigarette Smoking and Its Associated Therapy

Tobacco abuse treatment providers and manufacturers of treatment products are primarily focused on the creation of awareness among people and drug store owners about the severe effects of tobacco in order to expand their customer pool. For instance, cigarette smoking is a major cause of Buerger’s disease. Increasing awareness about these health hazards has prompted patients to choose smoking cessation therapy. Additionally. smoking cessation campaigns have also proved to be a major driver of the global buerger’s disease treatment market.

• Growing advancements in biologics

All contributing factors are the advances in advanced biologics, increased purchasing power, increased healthcare expenditure, and worldwide access to high-quality medications for middle- and poor-class families. On the other hand, the global buerger’s disease treatment market is predicted to increase quickly because of the enhanced treatment regarding early treatment and screening of buerger’s disease treatment and shift the market outlook. Consequently, growing advancements in biologics is creating huge opportunities for the growth of global buerger’s disease treatment market.

Opportunities

• Increase in Diagnostic Tests

There are varied diagnostic tests that are helping in increasing the growth of the market. Several tests such as Allen’s test, angiogram, tissue biopsy are contributing for the same. Rise in the number of blood tests for the diagnosis of Buerger’s disease is anticipated to expand the market growth. Furthermore, blood test is the primary test that a physician suggest to rule out the Buerger’s disease. This creates much opportunities for the market growth.

• Increased Clinical Research

Approvals for new treatments or therapies plays a major role in the growth of this market. For instance, in 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger's Disease. Additionally, Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger's disease. Thus, all these factors create much opportunities for the market growth.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professionals who are unable to perform the treatments could reduce the growth of the buerger’s disease treatment market over a forecast period.

• Low Awareness About Addiction Programs

Low awareness about addiction treatment products as well as awareness programs in developing countries is projected to restrain the market during the forecast period.

This buerger’s disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the buerger’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Buerger’s Disease Treatment Market Scope

The buerger’s disease treatment market is segmented on the basis of diagnosis type, treatment, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis Type

• Blood Test
• Allens’ Test
• Angiogram
• CT
• MRI 
• X-Ray
• Others
• Tissue Biopsy
• Others

Treatment

• Medication
• Surgery
• Others

End-Users

• Hospitals
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Buerger’s Disease Treatment Market Regional Analysis/Insights

The buerger’s disease treatment market is analyzed and market size insights and trends are provided by diagnosis, treatment, end-user and distribution channel as referenced above.

The major countries covered in the buerger’s disease treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the availability of funding for research and clinical trials.

Asia-Pacific is expected to account for the largest market share due to several significant factors such as the expansion of healthcare facilities and government support to enhance public health in the region.

La section par pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché du traitement mondial de la maladie de Buerger

Le paysage concurrentiel du marché du traitement de la maladie de Buerger fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du traitement de la maladie de Buerger

Les principaux acteurs opérant sur le marché du traitement de la maladie de Buerger comprennent :

• FUJIFILM Holdings Corporation (Japon)
• General Electric (États-Unis)
• Koninklijke Philips NV (Pays-Bas)
• Pluristem Inc. (Israël)
• Société Shimadzu (Japon)
• Siemens Healthcare GmbH (Allemagne)
• STEMPEUTICS RESEARCH PVT LTD. (Inde)
• Toshiba Medical Corporation (Japon)
• t2cure GmbH (Allemagne)

SKU-56134